Yano Shigetoshi, Hide Takuichiro, Shinojima Naoki
Department of Neurosurgery, Faculty of Life Sciences, Kumamoto University Graduate School, Kumamoto, Japan.
Department of Neurosurgery, Faculty of Life Sciences, Kumamoto University Graduate School, Kumamoto, Japan.
World Neurosurg. 2017 Mar;99:533-542. doi: 10.1016/j.wneu.2016.12.068. Epub 2016 Dec 23.
We report surgical results and complications of endoscopic endonasal skull base surgery for giant pituitary adenomas.
This study included 34 pituitary adenomas >40 mm treated by endoscopic endonasal skull base surgery between 2002 and 2015. Removal rates, symptoms, and complications were analyzed by direction of tumor extension.
Average tumor size was 45.5 mm. Near-total resection was achieved in 16 of 34 (47.1%) cases. Near-total resection was achieved significantly more often in anterior extension types and round tumor in superior extension types compared with multiple extension types. The average residual amount in 18 partial resection cases was 30.2% of preoperative volume, with no significant difference between groups. Regrowth after partial resection occurred in 8 cases, but repeated surgery or stereotactic radiotherapy controlled tumor growth and improved symptoms. Postoperative improvement of visual field deficits was achieved in 23 of 25 (92.0%) cases. Postoperative complications included visual deterioration (n = 1), cerebrospinal fluid leakage (n = 2), and cerebral infarction secondary to perforator injury (n = 2). Symptomatic intratumoral hemorrhage occurred in 1 multiple extension type.
Endoscopic endonasal skull base surgery enables less invasive and safer removal of various extension types of giant pituitary adenomas. Preservation of visual function is essential. Two-stage surgery or partial resection with additional treatments is possible without complications if a sufficient amount of resection is performed. In cases in which insufficient resection may be expected, alternative treatment, including combined-simultaneous resection, should be considered.
我们报告经鼻内镜颅底手术治疗巨大垂体腺瘤的手术结果及并发症。
本研究纳入2002年至2015年间接受经鼻内镜颅底手术治疗的34例直径>40 mm的垂体腺瘤。根据肿瘤扩展方向分析切除率、症状及并发症。
肿瘤平均大小为45.5 mm。34例中有16例(47.1%)实现了近全切除。与多方向扩展型相比,前向扩展型和上向扩展型中的圆形肿瘤实现近全切除的比例显著更高。18例部分切除病例的平均残留量为术前体积的30.2%,各亚组间无显著差异。部分切除后8例出现肿瘤复发,但再次手术或立体定向放射治疗控制了肿瘤生长并改善了症状。25例中有23例(92.0%)术后视野缺损得到改善。术后并发症包括视力恶化(1例)、脑脊液漏(2例)和穿支损伤继发脑梗死(2例)。1例多方向扩展型出现有症状的瘤内出血。
经鼻内镜颅底手术能够以微创且安全的方式切除各种扩展类型的巨大垂体腺瘤。保留视觉功能至关重要。如果切除量足够,二期手术或部分切除联合其他治疗不会出现并发症。对于预期切除不充分的病例,应考虑包括联合同步切除在内的替代治疗。